Prevalencia de candidemia por Candida abicans y Candida no albicans en el Hospital Universitario de La Samaritana 2008-2011
33 Páginas.
- Autores:
-
Jiménez Pérez, Luisa Fernanda
Varón Vega, Martha Liliana
- Tipo de recurso:
- Fecha de publicación:
- 2012
- Institución:
- Universidad de la Sabana
- Repositorio:
- Repositorio Universidad de la Sabana
- Idioma:
- spa
- OAI Identifier:
- oai:intellectum.unisabana.edu.co:10818/3365
- Acceso en línea:
- http://hdl.handle.net/10818/3365
- Palabra clave:
- Candidiasis
Infecciones nosocomiales
Hospitales-Saneamiento
- Rights
- License
- http://purl.org/coar/access_right/c_abf2
id |
REPOUSABA2_3d1769ba7d2ab6696ec13707b7ad3d73 |
---|---|
oai_identifier_str |
oai:intellectum.unisabana.edu.co:10818/3365 |
network_acronym_str |
REPOUSABA2 |
network_name_str |
Repositorio Universidad de la Sabana |
repository_id_str |
|
dc.title.es_CO.fl_str_mv |
Prevalencia de candidemia por Candida abicans y Candida no albicans en el Hospital Universitario de La Samaritana 2008-2011 |
title |
Prevalencia de candidemia por Candida abicans y Candida no albicans en el Hospital Universitario de La Samaritana 2008-2011 |
spellingShingle |
Prevalencia de candidemia por Candida abicans y Candida no albicans en el Hospital Universitario de La Samaritana 2008-2011 Candidiasis Infecciones nosocomiales Hospitales-Saneamiento |
title_short |
Prevalencia de candidemia por Candida abicans y Candida no albicans en el Hospital Universitario de La Samaritana 2008-2011 |
title_full |
Prevalencia de candidemia por Candida abicans y Candida no albicans en el Hospital Universitario de La Samaritana 2008-2011 |
title_fullStr |
Prevalencia de candidemia por Candida abicans y Candida no albicans en el Hospital Universitario de La Samaritana 2008-2011 |
title_full_unstemmed |
Prevalencia de candidemia por Candida abicans y Candida no albicans en el Hospital Universitario de La Samaritana 2008-2011 |
title_sort |
Prevalencia de candidemia por Candida abicans y Candida no albicans en el Hospital Universitario de La Samaritana 2008-2011 |
dc.creator.fl_str_mv |
Jiménez Pérez, Luisa Fernanda Varón Vega, Martha Liliana |
dc.contributor.advisor.none.fl_str_mv |
Calderón Vargas, Carlos Mauricio Granados, Carlos Eduardo Pérez Díaz, Carlos Eduardo |
dc.contributor.author.none.fl_str_mv |
Jiménez Pérez, Luisa Fernanda Varón Vega, Martha Liliana |
dc.subject.es_CO.fl_str_mv |
Candidiasis Infecciones nosocomiales Hospitales-Saneamiento |
topic |
Candidiasis Infecciones nosocomiales Hospitales-Saneamiento |
description |
33 Páginas. |
publishDate |
2012 |
dc.date.accessioned.none.fl_str_mv |
2012-08-14T19:28:14Z |
dc.date.available.none.fl_str_mv |
2012-08-14T19:28:14Z |
dc.date.created.none.fl_str_mv |
2012 |
dc.date.issued.none.fl_str_mv |
2012-08-14 |
dc.type.none.fl_str_mv |
bachelorThesis |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_7a1f |
dc.type.local.none.fl_str_mv |
Tesis de especialización |
dc.type.hasVersion.none.fl_str_mv |
publishedVersion |
dc.identifier.citation.none.fl_str_mv |
Darouiche R. Candida in the ICU. Clin Chest Med 2009; 30: 287–93. Arendrup M. Epidemiology of invasive candidiasis. Curr Opin Crit Care. 2010; 16:445–52. Galván B, Mariscal F. Epidemiología de la candidemia en UCI. Rev Iberoam Micol. 2006; 23: 12-15 Weinberger M, Leibovici L, Perez S, Samra Z, Ostfeld I, Levi I, Bash E, Turner D, Goldschmied A, Regev G, Pitlik S, Keller N. Characteristics of candidaemia with Candida albicans compared with non-albicans Candida species and predictors of mortality. J Hosp Infect. 2005; 61: 146–54 Krcmery V, Barnes A. Non-albicans Candida spp. causing fungaemia: Pathogenicity and antifungal resistance. J Hosp Infect. 2002; 50: 243-60. Grebo.org, Grupo Para el Control de la Resistencia Antimicrobiana en Bogotá GREBO. Disponible en: http://www.grebo.org Alvarez C, Cortés J, Sánchez R, Castillo J, Buitrago G, Meneses A. Boletín informativo GREBO. 2009; 2:3-24. Disponible en: http://www.grebo.org/Boletines/Boletin%20Informativo%20No2.pdf Cortés J, Leal A, Alvarez C. Frecuencia de aislamientos micóticos en hospitales de tercero y cuarto nivel en Bogotá, 2001- 2002. Infectio 2003; 7: 110. Leal A, Alvarez C, Cortés J, Meneses A, Ovalle M. Boletín informativo GREBO. 2010; 3:3-18. Disponible en: http://www.grebo.org/Boletines/Boletin%20GREBO%20Final%20julio%202011.pdf Pfaller MA, Diekema DJ, Jones RN, Sader HS, Fluit AC, Hollis RJ, Messer SA, and The SENTRY Participant Group. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 2001; 39: 3254-59 Gómez C. Resistencia de levaduras del género Candida al fluconazol [Suplemento 2]. Infectio 2010; 14: 172-80 Van de Veerdonk F, Kullberg B, Netea M. Patogenesis of invasive candidiasis. Curr Opin Crit Care. 2010; 16: 453-59. Bedout C, Gomez B. Candida y candidiasis invasora: un reto continuo para su diagnóstico temprano. [Suplemento 2]. Infectio. 2010; 14: 159-71. Cohen Y, Karubi P, Adrie C, Gauzit R, Marsepoil T, Zarka D, Clec'h C. Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients. Crit Care Med. 2010; 38(3): 826-30. Palacio A, Alhambra A, Cuetara M. Factores de riesgo de la candidiasis invasora: estratificación. Rev Iberoam Micol. 2006; 23: 29-31 Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg. 1994; 220(6):751-8 León C, Ruiz - Sanatana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez- Lema F, Garnacho J, León M. A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med. 2006; 34 (3): 730-37 Ostrosky L, Sable C, Sobel J, Alexander B, Donowitz G, Kan V, Kauffman C, Larsen R, Morrison V, Nucci M, Pappas P, Bradley M, Major S, Zimmer L, Wallace D, Dismukes W, Rex J. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis. 2007; 26: 271–76 Morrell M, Fraser V, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005; 39:3640–45. Garey KW, Rege M, Pai MP. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multiinstitutional study. Clin Infect Dis 2006; 43:25–31. Chow J, Golan Y, Ruthazer R, Karchmer A, Carmeli Y, Lichtenberg D, Chawla V, Young J, Hadley S. Factors Associated with Candidemia Caused by Non-albicans Candida Species Versus Candida albicans in the Intensive Care Unit. Clin Infec Dis. 2008; 46:1206–13. Slavin MA, Sorrell TC, Marriott D. Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death. J Antimicrob Chemother. 2010; 65:1042–51 Chi H, Yang Y, Shang S, Chen K, Yeh K, Chang F, Lin J. Candida albicans versus non-albicans bloodstream infections: The comparison of risk factors and outcome. J Microbiol Immunol Infect. 2011; 10: 1-7. Cuetara M, Palacio A, Alhambra A. Diagnóstico microbiológico tradicional de la candidiasis invasora en el enfermo crítico no neutropénico. Rev Iberoam Micol. 2006; 23: 4-7 Bille J. New nonculture-based methods for the diagnosis of invasive candidiasis. Curr Opin Crit Care. 2010; 16:460–64 Gómez A, Alvarez C, León A. Enfermedades Infecciosa en UCI: Una aproximación basada en la evidencia. Capitulo 7: Infecciones por Candida. Editorial Distribuna, 2004; 387-408 Vázquez O, Gutierrez P,Campos T, Martinez I, Romero R, Echeverría G, García G. Detección de antígeno manan de Candida en suero mediante anticuerpos monoclonales para el diagnóstico de candidiasis aguda diseminada. Rev Mex Patol Clin. 2002; 49 (4), 221-28 Eggimann P, Ostrosky-Zeichner L. Early antifungal intervention strategies in ICU patients. Curr Opin Crit Care. 2010; 16:465–69. Playford G, Lipman J, Sorrel T. Prophylaxis, empirical and preemptive treatment of invasive candidiasis. Curr Opin Crit Care. 2010; 16:470–74. Cruciani M, de Lalla F, Mengoli C. Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: A systematic review and metaanalysis. Intensive Care Med. 2005; 31:1479–87 Cruciani M, de Lalla F, Mengoli C. Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: A systematic review and metaanalysis. Intensive Care Med. 2005; 31:1479–87 Cruciani M, de Lalla F, Mengoli C. Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: A systematic review and metaanalysis. Intensive Care Med. 2005; 31:1479–87 |
dc.identifier.uri.none.fl_str_mv |
http://hdl.handle.net/10818/3365 |
dc.identifier.local.none.fl_str_mv |
157740 TE05558 |
identifier_str_mv |
Darouiche R. Candida in the ICU. Clin Chest Med 2009; 30: 287–93. Arendrup M. Epidemiology of invasive candidiasis. Curr Opin Crit Care. 2010; 16:445–52. Galván B, Mariscal F. Epidemiología de la candidemia en UCI. Rev Iberoam Micol. 2006; 23: 12-15 Weinberger M, Leibovici L, Perez S, Samra Z, Ostfeld I, Levi I, Bash E, Turner D, Goldschmied A, Regev G, Pitlik S, Keller N. Characteristics of candidaemia with Candida albicans compared with non-albicans Candida species and predictors of mortality. J Hosp Infect. 2005; 61: 146–54 Krcmery V, Barnes A. Non-albicans Candida spp. causing fungaemia: Pathogenicity and antifungal resistance. J Hosp Infect. 2002; 50: 243-60. Grebo.org, Grupo Para el Control de la Resistencia Antimicrobiana en Bogotá GREBO. Disponible en: http://www.grebo.org Alvarez C, Cortés J, Sánchez R, Castillo J, Buitrago G, Meneses A. Boletín informativo GREBO. 2009; 2:3-24. Disponible en: http://www.grebo.org/Boletines/Boletin%20Informativo%20No2.pdf Cortés J, Leal A, Alvarez C. Frecuencia de aislamientos micóticos en hospitales de tercero y cuarto nivel en Bogotá, 2001- 2002. Infectio 2003; 7: 110. Leal A, Alvarez C, Cortés J, Meneses A, Ovalle M. Boletín informativo GREBO. 2010; 3:3-18. Disponible en: http://www.grebo.org/Boletines/Boletin%20GREBO%20Final%20julio%202011.pdf Pfaller MA, Diekema DJ, Jones RN, Sader HS, Fluit AC, Hollis RJ, Messer SA, and The SENTRY Participant Group. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 2001; 39: 3254-59 Gómez C. Resistencia de levaduras del género Candida al fluconazol [Suplemento 2]. Infectio 2010; 14: 172-80 Van de Veerdonk F, Kullberg B, Netea M. Patogenesis of invasive candidiasis. Curr Opin Crit Care. 2010; 16: 453-59. Bedout C, Gomez B. Candida y candidiasis invasora: un reto continuo para su diagnóstico temprano. [Suplemento 2]. Infectio. 2010; 14: 159-71. Cohen Y, Karubi P, Adrie C, Gauzit R, Marsepoil T, Zarka D, Clec'h C. Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients. Crit Care Med. 2010; 38(3): 826-30. Palacio A, Alhambra A, Cuetara M. Factores de riesgo de la candidiasis invasora: estratificación. Rev Iberoam Micol. 2006; 23: 29-31 Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg. 1994; 220(6):751-8 León C, Ruiz - Sanatana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez- Lema F, Garnacho J, León M. A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med. 2006; 34 (3): 730-37 Ostrosky L, Sable C, Sobel J, Alexander B, Donowitz G, Kan V, Kauffman C, Larsen R, Morrison V, Nucci M, Pappas P, Bradley M, Major S, Zimmer L, Wallace D, Dismukes W, Rex J. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis. 2007; 26: 271–76 Morrell M, Fraser V, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005; 39:3640–45. Garey KW, Rege M, Pai MP. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multiinstitutional study. Clin Infect Dis 2006; 43:25–31. Chow J, Golan Y, Ruthazer R, Karchmer A, Carmeli Y, Lichtenberg D, Chawla V, Young J, Hadley S. Factors Associated with Candidemia Caused by Non-albicans Candida Species Versus Candida albicans in the Intensive Care Unit. Clin Infec Dis. 2008; 46:1206–13. Slavin MA, Sorrell TC, Marriott D. Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death. J Antimicrob Chemother. 2010; 65:1042–51 Chi H, Yang Y, Shang S, Chen K, Yeh K, Chang F, Lin J. Candida albicans versus non-albicans bloodstream infections: The comparison of risk factors and outcome. J Microbiol Immunol Infect. 2011; 10: 1-7. Cuetara M, Palacio A, Alhambra A. Diagnóstico microbiológico tradicional de la candidiasis invasora en el enfermo crítico no neutropénico. Rev Iberoam Micol. 2006; 23: 4-7 Bille J. New nonculture-based methods for the diagnosis of invasive candidiasis. Curr Opin Crit Care. 2010; 16:460–64 Gómez A, Alvarez C, León A. Enfermedades Infecciosa en UCI: Una aproximación basada en la evidencia. Capitulo 7: Infecciones por Candida. Editorial Distribuna, 2004; 387-408 Vázquez O, Gutierrez P,Campos T, Martinez I, Romero R, Echeverría G, García G. Detección de antígeno manan de Candida en suero mediante anticuerpos monoclonales para el diagnóstico de candidiasis aguda diseminada. Rev Mex Patol Clin. 2002; 49 (4), 221-28 Eggimann P, Ostrosky-Zeichner L. Early antifungal intervention strategies in ICU patients. Curr Opin Crit Care. 2010; 16:465–69. Playford G, Lipman J, Sorrel T. Prophylaxis, empirical and preemptive treatment of invasive candidiasis. Curr Opin Crit Care. 2010; 16:470–74. Cruciani M, de Lalla F, Mengoli C. Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: A systematic review and metaanalysis. Intensive Care Med. 2005; 31:1479–87 Cruciani M, de Lalla F, Mengoli C. Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: A systematic review and metaanalysis. Intensive Care Med. 2005; 31:1479–87 157740 TE05558 |
url |
http://hdl.handle.net/10818/3365 |
dc.language.iso.es_CO.fl_str_mv |
spa |
language |
spa |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
rights_invalid_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.publisher.none.fl_str_mv |
Universidad de La Sabana |
dc.publisher.program.none.fl_str_mv |
Especialización en Medicina Interna |
dc.publisher.department.none.fl_str_mv |
Facultad de Medicina |
publisher.none.fl_str_mv |
Universidad de La Sabana |
dc.source.none.fl_str_mv |
Universidad de La Sabana Intellectum Repositorio Universidad de La Sabana |
institution |
Universidad de la Sabana |
bitstream.url.fl_str_mv |
https://intellectum.unisabana.edu.co/bitstream/10818/3365/1/Luisa_Fernanda_Jimenez_Perez.pdf https://intellectum.unisabana.edu.co/bitstream/10818/3365/2/license.txt https://intellectum.unisabana.edu.co/bitstream/10818/3365/3/Luisa_Fernanda_Jimenez_Perez.pdf.txt |
bitstream.checksum.fl_str_mv |
eb5e0305d3998372945d493084f9cba7 f52a2cfd4df262e08e9b300d62c85cab 59ebeadc60edaf33d3316638e9481201 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Intellectum Universidad de la Sabana |
repository.mail.fl_str_mv |
contactointellectum@unisabana.edu.co |
_version_ |
1811952223118163968 |
spelling |
Calderón Vargas, Carlos MauricioGranados, Carlos EduardoPérez Díaz, Carlos EduardoJiménez Pérez, Luisa FernandaVarón Vega, Martha LilianaEspecialista en Medicina Interna2012-08-14T19:28:14Z2012-08-14T19:28:14Z20122012-08-14Darouiche R. Candida in the ICU. Clin Chest Med 2009; 30: 287–93.Arendrup M. Epidemiology of invasive candidiasis. Curr Opin Crit Care. 2010; 16:445–52.Galván B, Mariscal F. Epidemiología de la candidemia en UCI. Rev Iberoam Micol. 2006; 23: 12-15Weinberger M, Leibovici L, Perez S, Samra Z, Ostfeld I, Levi I, Bash E, Turner D, Goldschmied A, Regev G, Pitlik S, Keller N. Characteristics of candidaemia with Candida albicans compared with non-albicans Candida species and predictors of mortality. J Hosp Infect. 2005; 61: 146–54Krcmery V, Barnes A. Non-albicans Candida spp. causing fungaemia: Pathogenicity and antifungal resistance. J Hosp Infect. 2002; 50: 243-60.Grebo.org, Grupo Para el Control de la Resistencia Antimicrobiana en Bogotá GREBO. Disponible en: http://www.grebo.orgAlvarez C, Cortés J, Sánchez R, Castillo J, Buitrago G, Meneses A. Boletín informativo GREBO. 2009; 2:3-24. Disponible en: http://www.grebo.org/Boletines/Boletin%20Informativo%20No2.pdfCortés J, Leal A, Alvarez C. Frecuencia de aislamientos micóticos en hospitales de tercero y cuarto nivel en Bogotá, 2001- 2002. Infectio 2003; 7: 110.Leal A, Alvarez C, Cortés J, Meneses A, Ovalle M. Boletín informativo GREBO. 2010; 3:3-18. Disponible en: http://www.grebo.org/Boletines/Boletin%20GREBO%20Final%20julio%202011.pdfPfaller MA, Diekema DJ, Jones RN, Sader HS, Fluit AC, Hollis RJ, Messer SA, and The SENTRY Participant Group. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 2001; 39: 3254-59Gómez C. Resistencia de levaduras del género Candida al fluconazol [Suplemento 2]. Infectio 2010; 14: 172-80Van de Veerdonk F, Kullberg B, Netea M. Patogenesis of invasive candidiasis. Curr Opin Crit Care. 2010; 16: 453-59.Bedout C, Gomez B. Candida y candidiasis invasora: un reto continuo para su diagnóstico temprano. [Suplemento 2]. Infectio. 2010; 14: 159-71.Cohen Y, Karubi P, Adrie C, Gauzit R, Marsepoil T, Zarka D, Clec'h C. Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients. Crit Care Med. 2010; 38(3): 826-30.Palacio A, Alhambra A, Cuetara M. Factores de riesgo de la candidiasis invasora: estratificación. Rev Iberoam Micol. 2006; 23: 29-31Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg. 1994; 220(6):751-8León C, Ruiz - Sanatana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez- Lema F, Garnacho J, León M. A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med. 2006; 34 (3): 730-37Ostrosky L, Sable C, Sobel J, Alexander B, Donowitz G, Kan V, Kauffman C, Larsen R, Morrison V, Nucci M, Pappas P, Bradley M, Major S, Zimmer L, Wallace D, Dismukes W, Rex J. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis. 2007; 26: 271–76Morrell M, Fraser V, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005; 39:3640–45.Garey KW, Rege M, Pai MP. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multiinstitutional study. Clin Infect Dis 2006; 43:25–31.Chow J, Golan Y, Ruthazer R, Karchmer A, Carmeli Y, Lichtenberg D, Chawla V, Young J, Hadley S. Factors Associated with Candidemia Caused by Non-albicans Candida Species Versus Candida albicans in the Intensive Care Unit. Clin Infec Dis. 2008; 46:1206–13.Slavin MA, Sorrell TC, Marriott D. Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death. J Antimicrob Chemother. 2010; 65:1042–51Chi H, Yang Y, Shang S, Chen K, Yeh K, Chang F, Lin J. Candida albicans versus non-albicans bloodstream infections: The comparison of risk factors and outcome. J Microbiol Immunol Infect. 2011; 10: 1-7.Cuetara M, Palacio A, Alhambra A. Diagnóstico microbiológico tradicional de la candidiasis invasora en el enfermo crítico no neutropénico. Rev Iberoam Micol. 2006; 23: 4-7Bille J. New nonculture-based methods for the diagnosis of invasive candidiasis. Curr Opin Crit Care. 2010; 16:460–64Gómez A, Alvarez C, León A. Enfermedades Infecciosa en UCI: Una aproximación basada en la evidencia. Capitulo 7: Infecciones por Candida. Editorial Distribuna, 2004; 387-408Vázquez O, Gutierrez P,Campos T, Martinez I, Romero R, Echeverría G, García G. Detección de antígeno manan de Candida en suero mediante anticuerpos monoclonales para el diagnóstico de candidiasis aguda diseminada. Rev Mex Patol Clin. 2002; 49 (4), 221-28Eggimann P, Ostrosky-Zeichner L. Early antifungal intervention strategies in ICU patients. Curr Opin Crit Care. 2010; 16:465–69.Playford G, Lipman J, Sorrel T. Prophylaxis, empirical and preemptive treatment of invasive candidiasis. Curr Opin Crit Care. 2010; 16:470–74.Cruciani M, de Lalla F, Mengoli C. Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: A systematic review and metaanalysis. Intensive Care Med. 2005; 31:1479–87Cruciani M, de Lalla F, Mengoli C. Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: A systematic review and metaanalysis. Intensive Care Med. 2005; 31:1479–87Cruciani M, de Lalla F, Mengoli C. Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: A systematic review and metaanalysis. Intensive Care Med. 2005; 31:1479–87http://hdl.handle.net/10818/3365157740TE0555833 Páginas.La infección por Candida representa aproximadamente un 3% de todas las infecciones nosocomiales con una alta morbilidad y mortalidad. Ante el aumento de candidemia por Candida no albicans y la resistencia al tratamiento con azoles, es necesario determinar cuál es su prevalencia en la instituciones y la descripción de los posibles factores de riesgo adicionales asociados a su desarrollo. El objetivo de este estudio es establecer la prevalencia de candidemia causada por especies de Candida albicans como no albicans en el Hospital Universitario de La Samaritana y la descripción de posibles factores de riesgo asociados.spaUniversidad de La SabanaEspecialización en Medicina InternaFacultad de MedicinaUniversidad de La SabanaIntellectum Repositorio Universidad de La SabanaCandidiasisInfecciones nosocomialesHospitales-SaneamientoPrevalencia de candidemia por Candida abicans y Candida no albicans en el Hospital Universitario de La Samaritana 2008-2011bachelorThesisTesis de especializaciónpublishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_7a1fhttp://purl.org/coar/access_right/c_abf2ORIGINALLuisa_Fernanda_Jimenez_Perez.pdfLuisa_Fernanda_Jimenez_Perez.pdfVer documento en PDFapplication/pdf539632https://intellectum.unisabana.edu.co/bitstream/10818/3365/1/Luisa_Fernanda_Jimenez_Perez.pdfeb5e0305d3998372945d493084f9cba7MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-8498https://intellectum.unisabana.edu.co/bitstream/10818/3365/2/license.txtf52a2cfd4df262e08e9b300d62c85cabMD52TEXTLuisa_Fernanda_Jimenez_Perez.pdf.txtLuisa_Fernanda_Jimenez_Perez.pdf.txtExtracted Texttext/plain55973https://intellectum.unisabana.edu.co/bitstream/10818/3365/3/Luisa_Fernanda_Jimenez_Perez.pdf.txt59ebeadc60edaf33d3316638e9481201MD5310818/3365oai:intellectum.unisabana.edu.co:10818/33652021-05-28 17:30:52.479Intellectum Universidad de la Sabanacontactointellectum@unisabana.edu.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 |